{"Kunecatechins":{"SuperCategory":"Molecular entity","Comment":"taken from DrugBank","Id":"DB01266","Curator":"ab","Has role":"Drug","DefiningCitation":"http:\/\/www.drugbank.ca\/drugs\/DB01266","Definition":"Kunecatechins is a partially purified fraction of the water extract of green tea leaves from Camellia sinensis (L.) O Kuntze. Kunecatechins are involved in the clearance of genital and perianal warts. Pharmacology: Veregen is a botanical drug product for topical use. The drug substance in Veregen is Kunecatechins, which is a partially purified fraction of the water extract of green tea leaves from Camellia sinensis O Kuntze, and is a mixture of catechins and other green tea components. Veregen was approved by the FDA in October 2006. Mechanism of action: While the exact mechanism of action of catechins is unknown, they are powerful anti-oxidants and are linked to to evidence of fighting tumors as well as enhancing immune system function. Drug type: Approved. Nutraceutical. Small Molecule. Drug category: "}}